Back to ASND

Vestal Point Capital, LP → ASND

Vestal Point Capital, LP ASND Position History

Ascendis Pharma A/S • Healthcare

Quarters held
4
Latest value
$168.6M
Q3 2026
Peak value
$168.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$37.3M
Q1 2026$85.8M
Q2 2026$100M
Q3 2026$168.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$168.6M740.0K——
Q2 2026$100M375.0K——
Q1 2026$85.8M375.0K——
Q4 2025$37.3M175.0K——

Other funds holding ASND

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M